Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human Dab1 ELISA Kit (AC2474)
Cat.#: ASET-1063
Specifications
Description Human Dab1 ELISA Kit allows for the in vitro quantitative determination of human Dab1 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.188 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.313-20 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1803 Human CPE ELISA Kit (AC3214) Quantitative inquiry ASET-1872 Human 5HT1A Receptor ELISA Kit (AC3283) Quantitative inquiry ASET-1779 Mouse Vimentin ELISA Kit (AC3190) Quantitative inquiry ASET-2162 Rat AANAT ELISA Kit (AC3573) Quantitative inquiry ASET-1287 Rat Creatine Kinase B Type ELISA Kit (AC2698) Quantitative inquiry ASET-1389 Human Thyroid Hormone Receptor beta ELISA Kit (AC2800) Quantitative inquiry ASET-1483 Human Parvalbumin alpha ELISA Kit (AC2894) Quantitative inquiry ASET-2116 Mouse NG2 ELISA Kit (AC3527) Quantitative inquiry ASET-1123 Rat Calbindin ELISA Kit (AC2534) Quantitative inquiry ASET-1725 Human NPEPPS ELISA Kit (AC3136) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket